Recent Finacing
Recent Raise
Receptos is a San Diego biotechnology company developing GPCR-targeted therapeutics, advancing an S1P1 multiple sclerosis clinical candidate and IND-stage programs while offering its GPCR drug-discovery platform for selective partnerships.
